- Home
- PAVS vs AVTE Comparison
PAVS vs AVTE Comparison
Compare PAVS & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- AVTE
- Stock Information
- Founded
- PAVS 2004
- AVTE 2018
- Country
- PAVS United States
- AVTE United States
- Employees
- PAVS N/A
- AVTE N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- AVTE Health Care
- Exchange
- PAVS Nasdaq
- AVTE Nasdaq
- Market Cap
- PAVS 90.2M
- AVTE 72.5M
- IPO Year
- PAVS 2019
- AVTE 2021
- Fundamental
- Price
- PAVS $1.35
- AVTE $2.51
- Analyst Decision
- PAVS
- AVTE Hold
- Analyst Count
- PAVS 0
- AVTE 7
- Target Price
- PAVS N/A
- AVTE $11.75
- AVG Volume (30 Days)
- PAVS 5.6K
- AVTE 62.5K
- Earning Date
- PAVS 01-01-0001
- AVTE 03-27-2025
- Dividend Yield
- PAVS N/A
- AVTE N/A
- EPS Growth
- PAVS N/A
- AVTE N/A
- EPS
- PAVS N/A
- AVTE N/A
- Revenue
- PAVS $6,544,819.00
- AVTE N/A
- Revenue This Year
- PAVS N/A
- AVTE N/A
- Revenue Next Year
- PAVS N/A
- AVTE N/A
- P/E Ratio
- PAVS N/A
- AVTE N/A
- Revenue Growth
- PAVS N/A
- AVTE N/A
- 52 Week Low
- PAVS $0.32
- AVTE $1.25
- 52 Week High
- PAVS $1.85
- AVTE $30.29
- Technical
- Relative Strength Index (RSI)
- PAVS 45.04
- AVTE 51.75
- Support Level
- PAVS $1.33
- AVTE $2.45
- Resistance Level
- PAVS $1.40
- AVTE $2.56
- Average True Range (ATR)
- PAVS 0.03
- AVTE 0.08
- MACD
- PAVS -0.00
- AVTE 0.00
- Stochastic Oscillator
- PAVS 28.57
- AVTE 77.14
Stock Price Comparison Chart: PAVS vs AVTE
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.